Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - Cohen & Steers Income Opportunities REIT, Inc. (0001939433) (Filer)
Cohen & Steers Income Opportunities REIT, Inc. filed a Form 8-K with the SEC on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Sizzle Acquisition Corp. II (0002030663) (Filer)
Sizzle Acquisition Corp. II filed a Form 8-K with the SEC on October 13, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Oncotelic Therapeutics, Inc. (0000908259) (Filer)
Oncotelic Therapeutics, Inc. filed a Form 8-K with the SEC on October 13, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - COMMERCIAL METALS Co (0000022444) (Filer)
Commercial Metals Co filed a Form 8-K on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Capstone Holding Corp. (0000887151) (Filer)
Capstone Holding Corp filed an 8-K reporting a material definitive agreement, changes to security-holder rights, amendments to its articles of incorporation and bylaws, including a fiscal-year change, and accompanying financial statements and exhibits.
- 8-K - Bumble Inc. (0001830043) (Filer)
Bumble Inc. filed a Form 8-K on October 13, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - DANAHER CORP /DE/ (0000313616) (Filer)
Danaher Corp filed a Form 8-K on October 13, 2026, reporting departures, elections, appointments, and compensatory arrangements for certain officers under Item 5.02, and disclosing other events under Item 8.01.
- 8-K - DeFi Development Corp. (0001805526) (Filer)
DeFi Development Corp. filed a Form 8-K on October 13, 2026, reporting other events under Item 8.01 and including financial statements and exhibits under Item 9.01.
- 8-K - Workday, Inc. (0001327811) (Filer)
Workday, Inc. submitted a Form 8-K on October 13, 2026 (Accession No. 0001327811-26-000051, 165 KB), reporting an Item 8.01 Other Events disclosure and providing Item 9.01 financial statements and related exhibits.
- 8-K - BITMINE IMMERSION TECHNOLOGIES, INC. (0001829311) (Filer)
BITMINE IMMERSION TECHNOLOGIES, Inc. filed a Form 8-K with the SEC on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Phio Pharmaceuticals Corp. (0001533040) (Filer)
Phio Pharmaceuticals Corp. filed a Form 8-K with the SEC on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Ondas Inc. (0001646188) (Filer)
Ondas Inc. submitted a Form 8-K on October 13, 2026 (Accession No. 0001213900-26-108757), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - CervoMed Inc. (0001053691) (Filer)
CervoMed Inc. filed a Form 8-K with the SEC on October 13, 2026, reporting a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - SAB Biotherapeutics, Inc. (0001833214) (Filer)
SAB Biotherapeutics, Inc. filed a Form 8-K with the SEC on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - MetaVia Inc. (0001638287) (Filer)
MetaVia Inc. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - First Tracks Biotherapeutics, Inc. (0002091349) (Filer)
First Tracks Biotherapeutics, Inc. filed a Form 8-K on October 13, 2026 (Accession No. 0001193125-26-419761), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - California Resources Corp (0001609253) (Filer)
California Resources Corp filed a Form 8-K on October 13, 2026, reporting its results of operations and financial condition for the applicable period.
- 8-K - Horizon Space Acquisition I Corp. (0001946021) (Filer)
Horizon Space Acquisition I Corp filed a Form 8-K on October 13, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Eightco Holdings Inc. (0001892492) (Filer)
Eightco Holdings Inc. filed a Form 8-K on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Advasa Holdings, Inc. (0002084227) (Filer)
Advasa Holdings, Inc. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Newton Golf Company, Inc. (0001934245) (Filer)
Newton Golf Company, Inc. filed a Form 8-K on October 13, 2026 reporting that it received a notice of delisting for failing to satisfy a continued listing rule and that it is transferring its listing.
- 8-K - Runway Growth Finance Corp. (0001653384) (Filer)
Runway Growth Finance Corp. filed a Form 8-K on October 13, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - iBio, Inc. (0001420720) (Filer)
iBio, Inc. submitted a Form 8-K to the SEC on October 13, 2026, which includes a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Accelevation Holdings Corp. (0002141406) (Filer)
Accelevation Holdings Corp filed an 8-K on Oct 13 2026 reporting entry into and termination of material definitive agreements, creation of a direct financial obligation/off-balance sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Skydance Corp (0002041610) (Filer)
Skydance Corp filed a Form 8-K on October 13, 2026, reporting entry into a material definitive agreement, creation of a direct financial obligation, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - JOHNSON & JOHNSON (0000200406) (Filer)
Johnson & Johnson filed a Form 8-K on October 13, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and related exhibits.
- 8-K - Sunrise Realty Trust, Inc. (0002012706) (Filer)
Sunrise Realty Trust, Inc. filed a Form 8-K on October 13, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001829126-26-011033.
- 8-K - ONCOLYTICS BIOTECH INC (0001129928) (Filer)
Oncolytics Biotech Inc. filed a Form 8-K with the SEC on October 13, 2026, reporting under Item 8.01 (Other Events).
- 8-K - Cipher Digital Inc. (0001819989) (Filer)
Cipher Digital Inc. filed a Form 8-K on October 13, 2026, including a Regulation FD disclosure, other events, and accompanying financial statements and exhibits, under accession number 0001193125-26-419743.
- 8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)
Mirum Pharmaceuticals, Inc. filed a Form 8-K with the SEC on October 13, 2026, reporting under Item 8.01 (Other Events).